NT-219 | Interleukin Related interleukin-related.com

Product Name :
NT-219

Search keywords :
NT219

drugId :
null

Target Vo:
Signal transducer and activator of transcription 3

Target Vo Short Name :
STAT3

Moa_Name:
Insulin receptor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
TyrNovo Ltd

Active Company_Name :
TyrNovo Ltd

Active Indication_Name:
Colorectal Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ATF6 Antibody (YA831)
JAK2 Antibody (YA330)
Anti-Lactate Dehydrogenase A Antibody: Anti-Lactate Dehydrogenase A Antibody is an unconjugated, approximately 37 kDa, rabbit-derived, anti-Lactate Dehydrogenase A monoclonal antibody. Anti-Lactate Dehydrogenase A Antibody can be used for: WB, IHC-F, IHC-P, ICC/IF, IP expriments in human, mouse, rat background without labeling.

Author: Interleukin Related

Related Posts